Sign Up Today and Learn More About Synchron Stock
Invest in or calculate the value of your shares in Synchron or other pre-IPO companies through EquityZen's platform.
Synchron Stock
Synchron is a bioelectronics medicine company that develops neuromodulation solutions for previously-untreatable nervous system conditions.
About Synchron Stock
Founded
2016
Headquarters
Campbell, CA, US
Industries
Software, Artificial Intelligence, Data and Analytics
Synchron Press Mentions
Stay in the know about the latest news on Synchron
Neuralink hits $9B: Is Musk’s brain tech the future, or will Synchron and Precision Neuroscience take the lead?
techfundingnews • May 28, 2025
Apple wants to connect thoughts to iPhone control – and there's a very good reason for it
techradar • May 17, 2025
Apple Preparing to Launch Brain Signal-Control for iPhones
mactrast • May 17, 2025
Apple’s Brain-Control Technology Could Allow Users to Control iPhones With Their Brain: How Synchron’s Neural Implant Could Change the Way We Use iPhones Forever
techlusive • May 17, 2025
Apple's New Tech May Soon Let People Control iPhones With Their Brain
ndtv • May 17, 2025
Synchron Management
Leadership team at Synchron
CTO & Founder
Nicholas Opie
Chairman
Martin Dieck
Join now and verify your accreditation status to gain access to:
- Synchron Current Valuation
- Synchron Stock Price
- Synchron Management
- Available deals in Synchron and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Synchron Cap Table and Funding History by Share Class and Liquidity Preferences
- Synchron Revenue and Financials
- Synchron Highlights
- Synchron Business Model
- Synchron Risk Factors
- Synchron Research Report from SACRA Research
Trading Synchron Stock
How to invest in Synchron stock?
Accredited investors can buy pre-IPO stock in companies like Synchron through EquityZen funds. These investments are made available by existing Synchron shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Synchron stock?
Shareholders can sell their Synchron stock through EquityZen's private company marketplace. EquityZen's network includes over 370K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
